Assignee
VITAE PHARMACEUTICALS INC
US·30 granted patents·16 pending applications·191 citations·filing 2005–2018
Top patents by PatentIndex Score
46 records- 0197US9481674B1Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Nov 1, 2016·21 cites·6 claims
- 0295US9663515B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·13 cites·15 claims
- 0395US9266886B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted Feb 23, 2016·24 cites·31 claims
- 0494US10047085B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2017·Granted Aug 14, 2018·14 cites·20 claims
- 0594US9624217B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 18, 2017·14 cites·22 claims
- 0693US9868748B2Thiazolopyrrolidine inhibitors of ROR- γVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jan 16, 2018·13 cites·19 claims
- 0793US9796710B2Dihydropyrrolopyridine inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2016·Granted Oct 24, 2017·12 cites·14 claims
- 0892US10087184B2Dihydropyrrolopyridine inhibitors of RORγVITAE PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·10 cites·13 claims
- 0989US7858624B2Piperidine and morpholine renin inhibitorsVITAE PHARMACEUTICALS INC·Filed 2007·Granted Dec 28, 2010·7 cites·4 claims
- 1089US7754737B2Diaminoalkane aspartic protease inhibitorsVITAE PHARMACEUTICALS INC·Filed 2005·Granted Jul 13, 2010·16 cites·10 claims
- 1188US7872028B2Diaminopropanol renin inhibitorsVITAE PHARMACEUTICALS INC·Filed 2007·Granted Jan 18, 2011·14 cites·10 claims
- 1286US9416135B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Aug 16, 2016·4 cites·27 claims
- 1386US9073931B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2013·Granted Jul 7, 2015·5 cites·3 claims
- 1486US9006245B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2014·Granted Apr 14, 2015·5 cites·9 claims
- 1584US9006244B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2013·Granted Apr 14, 2015·5 cites·49 claims
- 1680US9845308B2Isoindoline inhibitors of ROR-gammaVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 19, 2017·2 cites·12 claims
- 1778US8383629B2Inhibitors of 11β-hydroxysteroid dehydrogenase type 1VITAE PHARMACEUTICALS INC·Filed 2009·Granted Feb 26, 2013·3 cites·27 claims
- 1875US9949975B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2016·Granted Apr 24, 2018·1 cites·4 claims
- 1975US9707232B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2016·Granted Jul 18, 2017·1 cites·19 claims
- 2073US9290477B2Inhibitors of β-secretaseVITAE PHARMACEUTICALS INC·Filed 2013·Granted Mar 22, 2016·2 cites·18 claims
- 2172US9388190B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Jul 12, 2016·1 cites·16 claims
- 2271US9526727B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 27, 2016·1 cites·12 claims
- 2371US9045500B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jun 2, 2015·1 cites·10 claims
- 2470US10336717B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2015·Granted Jul 2, 2019·1 cites·9 claims
- 2570US9212153B2Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2013·Granted Dec 15, 2015·1 cites·23 claims
- 2660US2018117041A1Liver x receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2017·Application pending·0 cites
- 2759US2018133220A1Compounds for use in treating acute coronary syndrome and related conditionsVITAE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2858US2018344734A1Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2018·Application pending·0 cites
- 2956US9814715B2Liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2016·Granted Nov 14, 2017·0 cites·16 claims
- 3055US9090605B2Substituted 5-,6- and 7-membered heterocycles, medicaments containing such compounds, and their useVITAE PHARMACEUTICALS INC·Filed 2014·Granted Jul 28, 2015·0 cites·17 claims
- 3152US2011105504A1Inhibitors Of 11beta-Hydroxysteroid Dehydrogenase Type 1VITAE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3252US2017231992A1Compounds for use in treating acute coronary syndrome and related conditionsVITAE PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 3352US2011136766A1Aurora kinase inhibitorsVITAE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3450US8372978B2Salts of methyl 2-((R)-(3-chlorophenyl)((R)-1-((S)-2-(methylamino)-3-((R)-tetrahydro-2H-pyran-3-yl)propylcarbamoyl)piperidin-3-yl)methoxy)ethylcarbamateVITAE PHARMACEUTICALS INC·Filed 2010·Granted Feb 12, 2013·0 cites·15 claims
- 3550US2013197034A1Salts Of Methyl 2-((R)-(3-Chlorophenyl)((R)-1-((S)-2-(Methylamino)-3-((R)-Tetrahydro-2H-Pyran-3-Yl)Propylcarbamoyl)Piperidin-3-Yl)Methoxy)EthylcarbamateVITAE PHARMACEUTICALS INC·Filed 2013·Application pending·0 cites
- 3650US2010010228A1Process for the asymmetric reduction of 3-benzoylpiperidinesVITAE PHARMACEUTICALS INC·Filed 2009·Application pending·0 cites
- 3749US2010184805A1Renin inhibitorsVITAE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3849US2010190829A1Renin inhibitorsVITAE PHARMACEUTICALS INC·Filed 2008·Application pending·0 cites
- 3946US2010298328A11-Heterocyclylamino-2-Hydroxy-3-Amino-Omega-ArylalkanesVITAE PHARMACEUTICALS INC·Filed 2007·Application pending·0 cites
- 4042US2016113930A1Compounds for use in treating rett syndromeVITAE PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4141US2015250787A1Compounds for use in treating skin cancersVITAE PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4240US2015239849A1Inhibitors of beta-secretaseVITAE PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 4340US2019010167A1Inhibitors of the menin-mll interactionVITAE PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 4436US10144715B2Piperazine derivatives as liver X receptor modulatorsVITAE PHARMACEUTICALS INC·Filed 2015·Granted Dec 4, 2018·0 cites·23 claims
- 4535US10654884B2Purine derivatives as CD73 inhibitors for the treatment of cancerVITAE PHARMACEUTICALS INC·Filed 2015·Granted May 19, 2020·0 cites·14 claims
- 4634US2010331320A1Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1VITAE PHARMACEUTICALS INC·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when VITAE PHARMACEUTICALS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →